Cyclophosphamide therapy is effective for bronchiolitis obliterans occurring as a late manifestation of lupus erythematosus.
Weber
F
F
Prior
C
C
Kowald
E
E
Schmuth
M
M
Sepp
N
N
D000328:Adult; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001989:Bronchiolitis Obliterans / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide